Summary:
UCLA, in collaboration with the NIAAA, is conducting a study to test a drug named ASP8062 as a possible treatment for alcohol use disorder. This study will look at how your craving for alcohol changes with the study drug and if you cut down or stop drinking alcohol while taking the study drug. This 6-week confidential trial consists of study medication, outpatient clinic visits and compensation.
Qualified Participants Must:
• Be at least 21 years of age
•
Have a desire to cut back or quit drinking alcohol
Qualified Participants May Receive:
Participants will be compensated up to $595 for participation.